![]() |
Volumn 84, Issue 3, 2000, Pages 474-477
|
Use of a new monoclonal antiboy-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism
a
|
Author keywords
Diagnosis; Pulmonary embolism; Soluble fibrin
|
Indexed keywords
ENZYME;
FIBRIN;
MONOCLONAL ANTIBODY;
DIAGNOSTIC AGENT;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CLINICAL TRIAL;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
ENZYME IMMUNOASSAY;
FEMALE;
HUMAN;
LUNG EMBOLISM;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEWBORN;
OUTPATIENT;
PRIORITY JOURNAL;
SCREENING TEST;
COHORT ANALYSIS;
DIAGNOSTIC ERROR;
EVALUATION;
MALE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
PREDICTION AND FORECASTING;
PROSPECTIVE STUDY;
ROC CURVE;
SENSITIVITY AND SPECIFICITY;
SOLUBILITY;
STANDARD;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
COHORT STUDIES;
DIAGNOSTIC ERRORS;
FEMALE;
FIBRIN;
HUMANS;
IMMUNOENZYME TECHNIQUES;
MALE;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROSPECTIVE STUDIES;
PULMONARY EMBOLISM;
ROC CURVE;
SENSITIVITY AND SPECIFICITY;
SOLUBILITY;
|
EID: 0034276553
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1614047 Document Type: Article |
Times cited : (3)
|
References (11)
|